Sector: Pharmaceuticals

Latest content

Microsoft leads tech brands bounceback, but other sectors suffer: WTR Brand Elite analysis

The WTR Brand Elite fell two points in October, hitting its lowest value this year. Yet technology companies – led by Microsoft – bucked the negative trend.

17 November 2023

General Court: EUIPO did not infringe principles of protection of legitimate expectations and legal certainty

The decision provides some clarity on the extent to which EUTM owners may rely on the principles of the protection of legitimate expectations and legal certainty.

03 November 2023

Apple and Hermès stock prices struggle, but companies have cause for optimism: WTR Brand Elite analysis

The WTR Brand Elite fell seven points in September, hitting its lowest value since 1 January 2023. However, the brands that experienced the biggest drop in value have reason to remain optimistic.

30 October 2023

Good news for Novartis in PASCOE v PASCELMO opposition

The General Court confirmed that there was no likelihood of confusion between Novartis’ mark PASCELMO and the earlier mark PASCOE, both covering Class 5 goods.

27 October 2023

Mankind not so kind to Novakind

A key finding was that the word ‘kind’ is not commonly used in the pharmaceutical industry and is not descriptive of pharmaceutical products.

24 October 2023

Why it is more crucial than ever for corporate trademark departments to promote themselves

As the deadline to nominate for the 2024 WTR Industry Awards approaches, our Saturday opinion column discusses why it is paramount for IP departments to promote themselves as their own brand.

21 October 2023

Top trademark filers across ASEAN unveiled

Data analysis reveals the companies with the largest trademark portfolios in the Association of Southeast Asian Nations – and evolving trends among the most active filers.

16 October 2023

Demand for weight-loss drugs highlights key factors for brand owners tackling opportunistic infringers

As Novo Nordisk and Eli Lilly work overtime to meet soaring demand for their popular diabetes and obesity drugs, trademark experts weigh in on what brand owners can do when opportunists take advantage of supply issues.

12 October 2023

Legal Updates you may have missed: how to prove genuine use of an EU trademark

We continue our latest series of pieces highlighting Legal Updates that you may have missed by looking at recent guidance by the EU General Court on what constitutes genuine use of an EU trademark.

03 October 2023

Get it right the first time: PROLÀCTEA v PROLACTAL, or the importance of having a strategy in opposition proceedings

This decision of the General Court considers a number of issues relating to the filing of evidence in opposition proceedings.

02 October 2023

Unlock unlimited access to all WTR content